07.06.2013 Views

Docetaxel with prednisone or prednisolone for the treatment of ...

Docetaxel with prednisone or prednisolone for the treatment of ...

Docetaxel with prednisone or prednisolone for the treatment of ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Glossary<br />

Absolute risk reduction The difference<br />

between <strong>the</strong> event rates in <strong>the</strong> two groups; if<br />

<strong>the</strong> adverse event rate is less in <strong>the</strong><br />

intervention group, this suggests that <strong>the</strong><br />

intervention is beneficial.<br />

Adverse effect/adverse event An abn<strong>or</strong>mal<br />

<strong>or</strong> harmful effect caused by, and attributable to,<br />

exposure to a chemical (e.g. a drug), which is<br />

indicated by some result such as death, a<br />

physical symptom <strong>or</strong> a visible illness. An event<br />

may be classified as adverse if it causes<br />

functional <strong>or</strong> anatomical damage, causes<br />

irreversible changes in <strong>the</strong> homeostasis <strong>of</strong> <strong>the</strong><br />

<strong>or</strong>ganism <strong>or</strong> increases <strong>the</strong> susceptibility <strong>of</strong> <strong>the</strong><br />

<strong>or</strong>ganism to o<strong>the</strong>r chemical <strong>or</strong> biological stress.<br />

Alopecia Baldness/loss <strong>of</strong> body hair.<br />

Anaemia An abn<strong>or</strong>mally low level <strong>of</strong> red<br />

blood cells in <strong>the</strong> blood. Red blood cells are<br />

responsible f<strong>or</strong> carrying oxygen around <strong>the</strong><br />

body.<br />

Antineoplastic Inhibiting <strong>or</strong> preventing <strong>the</strong><br />

development <strong>of</strong> neoplasms, and checking <strong>the</strong><br />

maturation and proliferation <strong>of</strong> malignant<br />

cells.<br />

Arthralgia Joint pain.<br />

© Queen’s Printer and Controller <strong>of</strong> HMSO 2007. All rights reserved.<br />

Health Technology Assessment 2007; Vol. 11: No. 2<br />

Glossary and list <strong>of</strong> abbreviations<br />

Technical terms and abbreviations are used throughout this rep<strong>or</strong>t. The meaning is usually clear from<br />

<strong>the</strong> context, but a glossary is provided f<strong>or</strong> <strong>the</strong> non-specialist reader. In some cases, usage differs in <strong>the</strong><br />

literature, but <strong>the</strong> term has a constant meaning throughout this review.<br />

As<strong>the</strong>nia Weakness, lack <strong>of</strong> energy and<br />

strength.<br />

Bias Deviation <strong>of</strong> results <strong>or</strong> inferences from<br />

<strong>the</strong> truth, <strong>or</strong> processes leading to such<br />

deviation. Any trend in <strong>the</strong> collection, analysis,<br />

interpretation, publication <strong>or</strong> review <strong>of</strong> data<br />

that can lead to conclusions that are<br />

systematically different from <strong>the</strong> truth.<br />

Blinding A procedure used in clinical trials<br />

to avoid <strong>the</strong> possible bias that might be<br />

introduced if <strong>the</strong> patient and/<strong>or</strong> doct<strong>or</strong> knew<br />

which <strong>treatment</strong> <strong>the</strong> patient would be<br />

receiving. If nei<strong>the</strong>r <strong>the</strong> patient n<strong>or</strong> <strong>the</strong> doct<strong>or</strong><br />

is aware <strong>of</strong> which <strong>treatment</strong> has been given, <strong>the</strong><br />

trial is termed ‘double-blind’. If only one <strong>of</strong> <strong>the</strong><br />

patient <strong>or</strong> doct<strong>or</strong> is aware, <strong>the</strong> trial is called<br />

‘single-blind’.<br />

Carcinoma A cancerous growth.<br />

Cens<strong>or</strong>ed data Cens<strong>or</strong>ship means that <strong>the</strong><br />

event does not occur during <strong>the</strong> period <strong>of</strong><br />

observation and <strong>the</strong> time <strong>of</strong> event is unknown,<br />

but <strong>the</strong>se cases are inc<strong>or</strong>p<strong>or</strong>ated into <strong>the</strong><br />

analysis. Those whose event is unknown <strong>or</strong> who<br />

are lost to <strong>the</strong> study (right cens<strong>or</strong>ed), <strong>or</strong> new<br />

patients introduced into <strong>the</strong> study (left<br />

cens<strong>or</strong>ed), add to <strong>the</strong> inf<strong>or</strong>mation on patients<br />

whose event time is known (uncens<strong>or</strong>ed) at<br />

each time interval.<br />

Chemo<strong>the</strong>rapy The use <strong>of</strong> drugs that are<br />

capable <strong>of</strong> killing cancer cells <strong>or</strong><br />

preventing/slowing <strong>the</strong>ir growth.<br />

Clodronate A medicine used to treat a high<br />

level <strong>of</strong> calcium in <strong>the</strong> blood caused by changes<br />

in <strong>the</strong> body that happen <strong>with</strong> cancer.<br />

Clodronate also treats <strong>the</strong> weakening in <strong>the</strong><br />

bones when cancer has spread to <strong>the</strong> bones<br />

from ano<strong>the</strong>r part <strong>of</strong> <strong>the</strong> body.<br />

Co-intervention In a randomised controlled<br />

trial, <strong>the</strong> application <strong>of</strong> additional diagnostic <strong>or</strong><br />

<strong>the</strong>rapeutic procedures to members <strong>of</strong> ei<strong>the</strong>r<br />

<strong>the</strong> experimental <strong>or</strong> reference group, <strong>or</strong> to<br />

both groups.<br />

continued<br />

vii

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!